Making best practice, everyday practice

Login Register

Bioresorbable polymer stents for high-risk coronary artery disease patients

BIO-RESORT trial: Encouraging results with ultra-thin new generation hybrid bioresorbable drug-eluting stents in high-risk coronary artery disease patients, with diabetes and small-vessel disease.

Do you like this? Share with a colleague